NEW YORK, May 1, 2015 /PRNewswire/ --
Moments ago, Analysts Review released new research updates concerning several important developing situations including JetBlue Airways Corporation (NASDAQ: JBLU), Comcast Corporation (NASDAQ: CMCSA), Rite Aid Corporation (NYSE: RAD), SuperValu Inc. (NYSE: SVU), and Alibaba Group Holding Limited (NYSE: BABA). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
JBLU Research Report: ( http://get.analystsreview.com/pdf/?c=JetBlue%20Airways&d=01-May-2015&s=JBLU ),
CMCSA Research Report: ( http://get.analystsreview.com/pdf/?c=Comcast%20Corporation&d=01-May-2015&s=CMCSA ),
RAD Research Report: ( http://get.analystsreview.com/pdf/?c=Rite%20Aid%20Corporation&d=01-May-2015&s=RAD ),
SUV Research Report: ( http://get.analystsreview.com/pdf/?c=SuperValu%20Inc.&d=01-May-2015&s=SUV ),
BABA Research Report: ( http://get.analystsreview.com/pdf/?c=Alibaba%20Group&d=01-May-2015&s=BABA ).
============
--
Analyst Update: Financial Results, Merger Deal, New Product, New Vaccines, and Hiring
Reviewed by: Rohit Tuli, CFA®
U.S. stocks tumbled on Thursday as Fed remained apprehensive about the interest rate outlook amid weaker than expected US first quarter economic data. The NASDAQ Composite was down 1.64%, to finish at 4941.42; the Dow Jones Industrial Average slipped 1.08%, to 17,840.52, and the S&P 500 ended 1.01% lower, at 2,085.51. Most importantly, the NASDAQ biotech index dropped 3.05% on Thursday and was down 8.1% in the past one week, led by disappointing earnings. European stocks gained on Thursday, supported by the strong euro and news of euro bloc's recovery from four consecutive months of deflation. Germany's DAX 30 rose 0.19%; France's CAC 40 jumped 0.14%, and the London's FTSE 100 closed 0.21% higher. Meanwhile, Asian markets mostly disappointed on Thursday. Japan's Nikkei, Australia's S&P ASX and Hong Kong's Hang Seng index all fell on Thursday.
JetBlue Airways (JetBlue) announced its financial results for Q1 2015 on April 28, 2015. Operating revenues were reported at $1.5 billion for Q1 2015, up 13.0% YoY, supported by healthy demand across its network. The Company reported a net income of $137 million, or $0.40 per diluted share in Q1 2015, compared to net income of $4 million, or $0.01 per diluted share in Q1 2014.
According to a press release dated April 24, 2015, Comcast Corp. has dropped its $45.2 billion merger deal with Time Warner Cable Inc. and transaction agreement with Charter Communications, Inc. In reference to the Time Warner deal, Comcast Chairman and CEO Brian L. Roberts issued a statement.
Rite Aid Pharmacies, on April 27, 2015, announced that its pharmacists are readily available to administer the whooping cough vaccine, Tdap, at all 139 Washington locations. Tdap vaccinations are available during pharmacy hours and no appointment is necessary.
SuperValu reported fourth quarter fiscal 2015 results on April 28, 2015. Net sales were $4.36 billion in Q4, up 10.4% YoY from $3.95 billion in the same period previous fiscal. Diluted EPS from continuing operations was $0.13, while adjusted diluted EPS was $0.24.
According to a Reuter's news published on April 29, 2015, Alibaba Group, a Chinese e-commerce giant, is freezing hiring for the rest of the year. As per the Company's report in January 2015, it had 34,081 employees at the end of 2014, a 63% increase from a year earlier.
--
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
